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doi:10.1016/j.jtcvs.2007.09.084186 The Journal of Thoracic and CardiBackground: Patients with calcified mediastinal lymph nodes who have hemoptysis
or lithoptysis represent a challenging therapeutic dilemma.
Methods: We performed a retrospective review of a prospective clinic and operative
database between January 1998 and December 2006. All patients had calcified medi-
astinal lymph nodes, symptoms or complications from these nodes, or both.
Results: There were 50 patients (23 men). Thirty-eight (76%) were symptomatic,
which included hemoptysis in 11, persistent cough in 8, and recurrent pneumonia
in 5, and all underwent rigid bronchoscopy. Thirty-four (89%) of the 38 symptomatic
patients had stones eroding into the airway (broncholiths), and 2 had an airway esoph-
ageal fistula. The most common location of the broncholith was in the bronchus inter-
medius (n5 19). Endoscopic removal of the broncholith was performed in 29 patients
and was successful in all. Elective thoracotomy with lymph node curettage, removal,
or both was performed in 5 patients. These 5 patients had no significant morbidity and
no operative mortality. Patients remained symptom free (median follow-up, 2.3 years;
range, 8–42 months). Twelve asymptomatic patients with calcified lymph nodes were
followed with serial computed tomographic scans and remain asymptomatic (median
follow-up, 3.1 years).
Conclusions: Broncholiths that are not fixed to the airway can be safely removed
with rigid and flexible bronchoscopic equipment. Thoracotomy with bron-
cholithectomy is also safe and effective and is reserved for symptomatic lesions
that cannot be removed bronchoscopically or for lesions that cause airway esoph-
ageal fistulas. Calcified nodes in asymptomatic patients are not an indication for
intervention.
B
roncholiths are calcified peribronchial lymph nodes that erode into the
adjacent airway and cause clinical and radiographic abnormalities.1 Most
broncholiths are a result of fungal infections, often Histoplasmosis capsula-
tum or mycobacterial granulomatous lymphadenitis, silicosis, or both.2,3 Patients be-
come symptomatic when the calcified lymph node impinges on or erodes into the
lumen of the airway. Bronchial distortion, irritation, and erosion by broncholiths
can cause chronic cough, hemoptysis, lithoptysis, recurrent pneumonia, and fistulas
between the bronchi and mediastinal structures, often the esophagus. Bronchoscopy
plays an important diagnostic and therapeutic role. However, many endoscopists
have reservations about removal because of the fear of massive hemorrhage, bronchial
injury, or both with attempted extraction of broncholiths bronchoscopically. Thus
many currently recommend avoiding bronchoscopic broncholithectomy4 and prefer
thoracotomy with broncholithotomy.5 In addition to these symptomatic patients,
some patients are sent for evaluation of large calcified mediastinal nodes that are
asymptomatic. The natural history of these patients has been poorly studied. The
purpose of this study was to review our endoscopic and thoracotomy experience in
symptomatic patients with broncholithiasis and to evaluate the 3-year natural history
of asymptomatic patients with calcified mediastinal lymph nodes.ovascular Surgery c July 2008
Cerfolio et al General Thoracic Surgery
G
TSAbbreviations and Acronyms
CT 5 computed tomography
Nd:YAG 5 neodymium-doped yttrium aluminum garnet
Materials and Methods
Definitions
Broncholithiasis is defined as bronchial inflammation or obstruction
caused by broncholiths. A broncholith is defined as a calcified struc-
ture or hard concretion that has part of its structure eroding into any
part of the tracheobronchial tree.6 It is visible during bronchoscopy,
and usually results from the erosion of a tuberculous or other gran-
ulomatous lymph node through the bronchial wall into the lumen.
Broncholiths were then subdivided as either mobile (also called
rockable) or fixed. Mobile broncholiths are defined as a broncholith
that is either loose in the airway or moves when probed with bron-
choscopic instruments during bronchoscopy. A fixed broncholith
(also referred to in this article as an airway stone) is defined as
a broncholith that does not exhibit any movement when probed
by the bronchoscope or by any instruments placed through it during
bronchoscopy.
We performed a retrospective cohort study using a prospective
operative database over an 8-year period. In addition, a prospective
database of patients evaluated in our clinic was also used. All
patients saw one surgeon in the clinic, and patients who underwent
surgical intervention were operated on by the same surgeon. The
inclusion criteria require patients with calcified mediastinal lymph
nodes that we evaluated in our clinic or patients with broncholiths
who underwent bronchoscopy or open operations. Patients less
than 19 years of age were excluded. This study was approved by
the University of Alabama’s Institutional Review Board. Patient
consent was obtained for entry into the operative and clinic data-
bases, and patients were informed that their data might be used
for research purposes.
Technique of Rigid Bronchoscopy
Rigid bronchoscopy was performed as described at length previ-
ously.7 Briefly, patients underwent general anesthesia, a tooth guard
was placed on the patient’s upper teeth, the neck was extended, and,
most commonly, a rigid number 8 bronchoscope was inserted
through the vocal cords under direct vision with the aid of a hand-
held laryngoscope. Conversion from rigid bronchoscopy to formal
laryngoscopy with epiglottic suspension is always available. Once
the rigid bronchoscope is in the upper trachea, jet ventilation is es-
tablished. Jet ventilation is carried out through a side channel of the
rigid bronchoscope, thus enabling the surgeon more room to work
through the end of the scope concomitantly while still oxygenating
and ventilating the patient. Ventilation occurs through the open end
of the rigid bronchoscope. A flexible bronchoscope can then be
easily placed down through the rigid scope, and the entire airway
can be evaluated. The offending broncholith is identified and is
probed to determine whether it is fixed to the sides of the airway
or whether it is mobile. If bleeding occurs from vascular granulation
tissue around the airway stone, then a neodymium-doped yttrium
aluminum garnet (Nd:YAG) or holmium laser can be used as previ-
ously described.8 In addition, an Nd:YAG or holmium laser can beThe Journal of Thorused to directly laser the stone in selected patients. If the stone is
loose or becomes loose after manipulation, then it is removed
through a 0 lens straight-A head grasper. If it cannot be grabbed
and removed, a 4- to 8-mm angioplasty balloon catheter is posi-
tioned beyond the stone and then inflated and pulled proximally to
pull the stone into the more proximal airway. Irrigation is then
used to ensure all small fragments are removed, and the distal airway
is then inspected to ensure all subsegments are recruited.
Thoracotomy With Lymph Node Removal
or Curettage
Patients who have persistent symptoms, recalcitrant tracheobron-
chial fistulas, or both to other mediastinal structures often require
thoracotomy. The goal of the operation is broncholithectomy
through a bronchotomy, repair of the airway and takedown of the
fistula, the interposition of a pedicled muscle flap in between the 2
structures (usually we use an intercostal muscle), and removal of
all calcified mediastinal (N2) nodes, as well as calcified hilar (N1)
nodes, that can be safely removed without the concomitant removal
of nondiseased pulmonary parenchyma. Lymph nodes that cannot
be safely removed, such as the subcarinal node, because of tenacious
attachment to surrounding vital structures (ie, esophagus, carina,
and superior vena cava) should be incised, and curettage should
be used as previously described.5 This allows for removal of the
caseating material, calcified material, or both that fills the lymph
node yet leaves the outer shell of the lymph node in place. This
technique is safe because the outer wall of the lymph node serves
as a protective border to help prevent injury to surrounding struc-
tures. The entire material, however, inside the lymph node must
be removed so the walls of the lymph node collapse.
Results
Between January 1998 and December 2006, there were 50
patients (23 men) who met the eligibility criteria for this
study. Twelve (24%) patients were asymptomatic and were
referred for calcified mediastinal lymph nodes that were inci-
dentally discovered during computed tomographic (CT)
scans performed for other reasons. The remaining 38 (76%)
patients were symptomatic. Figure 1 shows the results for
these symptomatic patients. The most common presenting
symptoms included hemoptysis (11 patients), persistent
cough (8 patients), and recurrent pneumonia (5 patients).
Other symptoms included chest pain in 4 patients, dyspnea
in 4 patients, dysphagia in 2 patients, and malaise, hemopty-
sis, excessive sputum, and wheezing in 1 patient each. All
patients underwent rigid bronchoscopy with a flexible bron-
choscope placed through the rigid scope, as described in the
Materials and Methods sections. We found broncholiths
eroding into the airway in 32 patients, an esophageal fistula
in 2 patients (both on the right bronchial tree), and calcified
mediastinal lymph nodes compressing parts of the airway
in the remaining 4 symptomatic patients. These 4 patients un-
derwent bronchoscopic dilation and 3-month therapy with
itraconazole (Sporonax; Janssen–Ortho, Toronto Ontario,
Canada) because all 4 had extensive bilateral mediastinal
and hilar disease. One patient required the placement ofacic and Cardiovascular Surgery c Volume 136, Number 1 187
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TSFigure 1. Treatment results for the 38
symptomatic patients. *Recommended
length of treatment is 3 months.percutaneously placed stents in the right pulmonary veins and
a stent in the bronchus intermedius. He has required 2 rigid
bronchoscopies and lasering because of some mild granula-
tion tissue over the past 1.5 years.
The location of the broncholiths is shown in Figure 2. The
most common location was the bronchus intermedius (n 5
19). Twenty-nine broncholiths were mobile, as defined in
the Materials and Methods section, during endoscopic evalu-
ation, and 14 were immobile. Endoscopic stone removal was
successful without significant bleeding in all 29 patients.
These 29 patients have a median follow-up of 4.2 years
and have had no significant recurrences of broncholiths, al-
though 3 required subsequent procedures to remove other
broncholiths that moved into their airway. Elective thoracot-
omy with lymph node curettage, removal, or both was per-
formed in 5 patients. These 5 patients had no significant
morbidity or operative mortality and remain symptom free
(median follow-up, 2.3 years; range, 8–42 months). The 12
asymptomatic patients with calcified lymph nodes were
followed with serial CT scans and also remain asymptomatic
(median follow-up, 3.1 years).
Discussion
This retrospective study describes results on 4 different
subsets of patients with calcified mediastinal lymph nodes.
First, it demonstrates the safe and successful endoscopic
management of broncholiths in a subset of patients who
have broncholiths that are not fixed in the airway. Second,
it shows the safe and effective results of thoracotomy in a sub-
set of patients who have fixed broncholiths that are not safely188 The Journal of Thoracic and Cardiovascular Surgery c Julyremovable endoscopically and who have persistent symp-
toms or fistulas caused by the broncholith. These patients
can undergo broncholithectomy with good short- and long-
term results through a thoracotomy. The third group includes
patients whose calcified lymph nodes have not eroded into
the airway. We have shown that the 3-year natural history
of these patients seems to be benign, and prophylactic
surgical resection might not be warranted because of the
Figure 2. Anatomic location and number of broncholiths (n 5 50).2008
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the fourth group of patients is the most challenging. These are
patients with large hilar and mediastinal lymph nodes that are
compressing but not invading the airway. These patients
probably represent a spectrum of mediastinal scarring that
can culminate into full-blown idiopathic mediastinal fibrosis,
which is also referred to as chronic fibrosis mediastinitis or
chronic mediastinal fibrosis. This inflammatory and devas-
tating disease is a process of not just calcified mediastinal
lymph nodes but can become, in selected patients, a slow,
progressive, insidious growth of fibrotic tissue that progres-
sively envelopes all mediastinal structures. It has the poten-
tial to constrict or occlude any mediastinal structure and
can be fatal in otherwise young healthy patients. These pa-
tients are often managed with dilation (and/or stenting of
the appropriate constricted structures).
The key to success to most surgical procedures is patient
selection. Brantigan in 19784 concluded that bronchoscopic
broncholithectomy should be avoided in all patients because
of the high risk of massive hemoptysis. Trastek and col-
leagues5 from the Mayo Clinic in 1985 stated that ‘‘broncho-
lithectomy via thoracotomy is the preferred treatment.’’
Hence many thoracic surgeons have been trained to avoid at-
tempts at removal of airway broncholiths. However, 15 years
later, the same institution updated their practice on patients
with broncholiths and included 26 patients who underwent
endoscopic removal.9 In the more recent series they reported
that endoscopic removal is safe in properly selected patients.
Similarly, Manivale and Deslee in 200510 reported the
successful endoscopic removal of loose broncholiths in 2 pa-
tients, and Olsen and associates in 199611 concluded that
‘‘bronchoscopy is a safe and effective therapeutic option
for the management of loose broncholiths.’’ Yet despite these
reports, many surgeons suggest that endoscopic removal
should not be attempted because of the risk of massiveThe Journal of Thorhemoptysis and other complications.12 We believe the best
treatment depends on the characteristic of the broncholith,
its size, its location, its proximity to the pulmonary artery
on the chest CT scan, and the patient’s symptoms.
The similar characteristics of most patients who undergo
successful endoscopic removal is a broncholith that is not
fixed in the airway (or at least partially mobile on bron-
choscopic probing), is small enough to be removed endo-
scopically, is proximal enough in the airway to facilitate
removal, and is not contiguous with the pulmonary artery
on the CT scan. If a broncholith is contiguous with the pul-
monary artery, aggressive manipulation can be dangerous;
however, if it is near any large vascular structures, a more ag-
gressive probing and perhaps even lasering might be safe. In
2006, Ferguson and colleagues13 reported the use of a laser
and lithotripsy to help break apart a broncholith, and as
seen in this series, we too have used the Nd:YAG and hol-
mium lasers for airway stones. However, the CT scan must
be carefully evaluated, the proximity of the pulmonary artery
or other vessels must be carefully considered, and the amount
of broncholith outside the airway must also be considered.
Unlike many other surgical series, this study also includes
a nonoperative clinic database. Although we did not start the
clinic database at the same time as the surgical database, we
have been able to track patients who did not come to the
surgical arena. This allows us to report the total number of pa-
tients, as opposed to only those who underwent a surgical in-
tervention. Importantly, there have been no previous reports
on the natural history of calcified mediastinal and hilar lymph
nodes in asymptomatic patients. Patients have been referred
to us for prophylactic thoracotomy because of the fear of pro-
gression of disease. However, this article shows that the
3-year natural history of these patents appears to be benign.
The nodes do not necessary rub their way into the airway
or cause a fistula between mediastinal structures or lead toG
TSFigure 3. Our preferred algorithm for
the care of patients with broncholiths
in the airway, calcified mediastinal
lymph nodes abutting the airway, or
both.acic and Cardiovascular Surgery c Volume 136, Number 1 189
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patients seem to have no progression of disease, either radio-
logically or by the development of symptoms over a median
of 3.1 years. This suggests these patients can be followed on
a yearly basis or perhaps even less stringently with CT scans.
Intervention might not be warranted unless patients become
symptomatic. These comments are for patients without active
inflammatory disease and reserved for those with burnt-out
calcified nodal disease. However, symptomatic patients who
have superior vena cava syndrome or progressive pulmonary
venous obstruction probably are better given diagnoses of
idiopathic mediastinal fibrosis as opposed to broncholithiasis.
Their treatment is quite different, and their disease is more
aggressive, with greater morbidity, and can be fatal.
Based on our experience, we have presented an algorithm
for the current management of patients with broncholiths, as
shown in Figure 3. As seen, the major determining factor is
the patient’s symptoms. Patients who have a fistula that is
caused by the stone require intervention but not necessarily
thoracotomy. Stone removal and observation is one option,
and stone removal with temporary stenting of the airway or
esophagus (if the fistula is between the airway and the
esophagus) is another. However, open thoracotomy with
broncholithectomy and buttressing of the airway closure
with a muscle flap to interpose pedicled muscle between
the 2 structures is the most conservative therapy and offers
definitive and complete repair.
In conclusion, despite previous reports, broncholiths that
are not fixed in the airway can be safely removed with rigid
and flexible bronchoscopic equipment. Thoracotomy with
broncholithectomy appears safe and effective and is reserved190 The Journal of Thoracic and Cardiovascular Surgery c Julfor symptomatic lesions that cannot be removed broncho-
scopically or for lesions that cause airway esophageal fistula.
The removal of other ipsilateral calcified lymph nodes during
that operation is safe. Calcified nodes in asymptomatic
patients are not an indication for intervention.
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